Literature DB >> 12746460

Sphingolipid requirement for generation of a functional v1 component of the vacuolar ATPase.

Ji-Hyun Chung1, Robert L Lester, Robert C Dickson.   

Abstract

There has been no previous indication that vacuolar ATPases (V-ATPases) require sphingolipids for function. Here we show, by using Saccharomyces cerevisiae sur4Delta and fen1Delta cells, that sphingolipids with a C26 acyl group are required for generating V1 domains with ATPase activity. Sphingolipids in sur4Delta cells contain C22 and C24 acyl groups instead of C26 acyl groups whereas about 30% of the sphingolipids in fen1Delta cells have C26 acyl groups and the rest have C22 and C24 acyl groups. sur4Delta cells have several phenotypes (vacuolar membrane ATPase, Vma-) that indicate a defect in the V-ATPase, and vacuoles purified from sur4Delta cells have little to no ATPase activity. These phenotypes are less pronounced in fen1Delta cells, consistent with the idea that the C26 acyl group in sphingolipids is necessary for V-ATPase activity. Other results show that the two V-ATPase domains, V1 and V0, are assembled and delivered to the vacuolar membrane in sur4Delta cells similar to wild-type cells. In vitro assembly studies show that V1 from sur4Delta cells associates with wild-type V0 but the complex lacks V-ATPase activity, indicating that V1 is defective. Reciprocal experiments with V0 from sur4Delta cells show that it is normal. We conclude that sphingolipids with a C26 acyl group are required for generating fully functional V1 domains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746460     DOI: 10.1074/jbc.M300943200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  A genomic screen for yeast vacuolar membrane ATPase mutants.

Authors:  Maria Sambade; Mercedes Alba; Anne M Smardon; Robert W West; Patricia M Kane
Journal:  Genetics       Date:  2005-06-03       Impact factor: 4.562

Review 2.  Roles for sphingolipids in Saccharomyces cerevisiae.

Authors:  Robert C Dickson
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Sphingomyelin is important for the cellular entry and intracellular localization of Helicobacter pylori VacA.

Authors:  Vijay R Gupta; Brenda A Wilson; Steven R Blanke
Journal:  Cell Microbiol       Date:  2010-10       Impact factor: 3.715

Review 4.  Yeast sphingolipids: recent developments in understanding biosynthesis, regulation, and function.

Authors:  L Ashley Cowart; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2006-08-10

5.  Effects on vesicular transport pathways at the late endosome in cells with limited very long-chain fatty acids.

Authors:  Keisuke Obara; Ryo Kojima; Akio Kihara
Journal:  J Lipid Res       Date:  2013-01-16       Impact factor: 5.922

6.  Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis.

Authors:  Danielle Kemmer; Lianne M McHardy; Shawn Hoon; Delphine Rebérioux; Guri Giaever; Corey Nislow; Calvin D Roskelley; Michel Roberge
Journal:  BMC Microbiol       Date:  2009-01-14       Impact factor: 3.605

7.  Structure of the Lipid Nanodisc-reconstituted Vacuolar ATPase Proton Channel: DEFINITION OF THE INTERACTION OF ROTOR AND STATOR AND IMPLICATIONS FOR ENZYME REGULATION BY REVERSIBLE DISSOCIATION.

Authors:  Nicholas J Stam; Stephan Wilkens
Journal:  J Biol Chem       Date:  2016-12-13       Impact factor: 5.157

Review 8.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

9.  TOR complex 2-Ypk1 signaling maintains sphingolipid homeostasis by sensing and regulating ROS accumulation.

Authors:  Brad J Niles; Amelia C Joslin; Tara Fresques; Ted Powers
Journal:  Cell Rep       Date:  2014-01-23       Impact factor: 9.423

10.  Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs.

Authors:  Yong-Qiang Zhang; Soledad Gamarra; Guillermo Garcia-Effron; Steven Park; David S Perlin; Rajini Rao
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.